As of November 6, 2026, Pulmonx Corp is a publicly traded company (Nasdaq: LUNG); its largest reported holder is Primecap Management Co., with 10.26% on Schedule 13G/A of November 5, 2026, then Morgan Stanley (6.9%). The largest insider holding is Glendon E. French III, the chief executive and president, with 2,056,134 shares (4.7% of shares outstanding), per Form 4 of September 3, 2026 (Schedule 13G/A, November 5, 2026).
Is this your company?
About to sign with, pay or invest in Pulmonx Corp? See the free Snapshot first.
Free to see. No signup.
Is Pulmonx Corp a real, registered company?
- Pulmonx Corp files with the SEC under CIK 1127537 (its SEC filings).
- Its shares are listed under the ticker LUNG on Nasdaq (SEC company record).
- Incorporated in Delaware; business address in Redwood City, California, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Pulmonx Corp in our court records and SEC 8-K records (as of 2026-11-06).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Primecap Management Co. (filed 2026-11-05).
Who are Pulmonx Corp's owners and officers?
Pulmonx Corp: incorporated in Delaware; business address in Redwood City, California; industry Surgical & Medical Instruments & Apparatus (Schedule 13G/A, 2026-11-05).
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-11-05 | Primecap Management Co/Ca/ | 10.26% |
| Schedule 13G/A, 2026-08-13 | Morgan Stanley | 6.9% |
| Schedule 13G/A, 2026-07-29 | Blackrock, Inc. | 1.8% |
| Schedule 13G/A, 2026-03-27 | The Vanguard Group | 0% |
| Schedule 13G, 2026-03-09 | Soleus Capital Master Fund, L.P. | 6.5% |
| Schedule 13G/A, 2025-11-13 | Primecap Management Co/Ca/ | 12.16% |
| Schedule 13G/A, 2025-11-07 | Fmr LLC | 0.2% |
| Schedule 13G/A, 2025-09-08 | Fmr LLC | 5.4% |
| Schedule 13G/A, 2025-08-06 | Fmr LLC | 10.6% |
Questions about who owns Pulmonx Corp
Who owns Pulmonx Corp?
On this page, 3 holders' latest ownership filings report 5% or more of Pulmonx Corp: Primecap Management Co/Ca/ (10.26%, Schedule 13G/A, filed 2026-11-05), Morgan Stanley (6.9%, Schedule 13G/A, filed 2026-08-13) and Soleus Capital Master Fund, L.P. (6.5%, Schedule 13G, filed 2026-03-09).
Who are the largest shareholders of Pulmonx Corp?
By the share each holder's latest filing reports, the largest holders of Pulmonx Corp on this page are Primecap Management Co/Ca/ (10.26%), Morgan Stanley (6.9%) and Soleus Capital Master Fund, L.P. (6.5%).
When did Primecap Management Co/Ca/ buy into Pulmonx Corp?
The filings give report dates, not purchase dates. The earliest filing from Primecap Management Co/Ca/ on this page is the Schedule 13G/A, filed 2025-11-13, reporting 12.16%; its latest, Schedule 13G/A filed 2026-11-05, reports 10.26%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 9 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Pulmonx Corp?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Pulmonx Corp: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Pulmonx Corp covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
15 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Which insiders own Pulmonx Corp shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , the chief executive and president: 2,056,134 shares (4.7% of shares outstanding), 1,137,936 held directly and 918,198 indirectly (Form 4, 2026-09-03).
- , the chief operating officer and chief financial officer: 1,335,319 shares (3.1% of shares outstanding) (Form 4, 2025-12-03).
- , the chief commercial officer: 449,832 shares (1.0% of shares outstanding) (Form 4, 2026-09-03).
- , the general counsel: 361,827 shares (0.83% of shares outstanding) (Form 4, 2026-09-03).
- , the chief executive and president: 358,967 shares (0.82% of shares outstanding) (Form 4, 2025-09-03).
Shares outstanding: 43,550,665 as of 2026-10-29, from the company's latest SEC cover page.
How much has Pulmonx Corp raised?
No fundraising or offering filing from Pulmonx Corp is on file with us.
Keep reading
More on Pulmonx Corp and the records around it.
Pulmonx Corp elsewhere on the record
- 5%+ stake filings Nov 2026
Companies that share a holder
- PRIMECAP MANAGEMENT CO/CA/ also filed stake reports on 24 other companies: Xencor Inc (Nov 2026), GRAIL, Inc. (Nov 2026), MARKETAXESS HOLDINGS INC (Nov 2026)
- Soleus Capital Master Fund, L.P. also filed stake reports on 24 other companies: Beta Bionics, Inc. (Nov 2026), Evolus, Inc (Nov 2026), INSPIRE MEDICAL SYSTEMS, INC. (Nov 2026)
- Morgan Stanley also filed stake reports on 182 other companies: MDA Space Ltd. (Nov 2026), RiverNorth/DoubleLine Strategic Opportunity Fund, Inc. (Oct 2026), Arbutus Biopharma Corp (Oct 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/pulmonx